PhilipRJohnsonMD

PubMed

• Recombinant adeno-associated virus vector genomes take the form of long-lived, transcriptionally competent episomes in human muscle.
  Schnepp, B.,Chulay, J. D.,Ye, G. J.,Flotte, T. R.,Trapnell, B. C.,Johnson, P. R.> ;Hum. Gene Ther.. 2015 Dec 10
• Adeno-associated virus delivery of broadly neutralizing antibodies.
  Schnepp, B. C.,Johnson, P. R.> ;Curr Opin HIV AIDS. 2014 Mar 19
• Proof of principle for epitope-focused vaccine design.
  Correia, B. E.,Bates, J. T.,Loomis, R. J.,Baneyx, G.,Carrico, C.,Jardine, J. G.,Rupert, P.,Correnti, C.,Kalyuzhniy, O.,Vittal, V.,Connell, M. J.,Stevens, E.,Schroeter,...> ;Nature. 2014 Feb 07
• A Novel Self-Replicating Chimeric Lentivirus-Like Particle.
  Jurgens, C.K., Young, K., Madden, V.J., Johnson, P.R., Johnston, R.E.> ;J Virol. 2012 Jan
• A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus.
  Vardas, E., Kaleebu, P., Bekker, L., Hoosen, A., Chomba, E., Johnson, P.R., Anklesaria, P., Birungi, J., Barin, B., Boaz, M., Cox, J., Lehrman, J., Stevens, G., Gilmou...> ;AIDS Res Hum Retroviruses. 2010 Aug
• Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys.
  Johnson, P.R., Schnepp, B.C., Zhang, J., Connell, M.J., Greene, S.M., Yuste, E., Desrosiers, R.C., Clark, K.R.> ;Nat Med. 2009-08-01
• Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.
  Oscherwitz, J., Yu, F., Jacobs, J.L., Liu, T., Johnson, P.R., Cease, K.B.> ;Infect Immun. 2009-08-01
• Prevalence of human bocavirus in human tonsils and adenoids.
  Clément, N., Battaglioli, G., Jensen, R. L., Schnepp, B. C., Johnson, P. R., St George, K., Linden, R. M.> ;Emerg Infect Dis. 2009-07-01
• Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors.
  Liu, T., Oscherwitz, J., Schnepp, B., Jacobs, J., Yu, F., Cease, K.B., Johnson, P.R.> ;Mol Ther. 2009-02-01
• Infectious molecular clones of adeno-associated virus isolated directly from human tissues.
  Schnepp, B.C., Jensen, R.L., Clark, K.R., Johnson, P.R.> ;J Virol. 2009-02-01
• A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.
  Mehendale, S., van Lunzen, J., Clumeck, N., Rockstroh, J., Vets, E., Johnson, P.R., Anklesaria, P., Barin, B., Boaz, M., Kochhar, S., Lehrman, J., Schmidt, C., Peeters...> ;AIDS Res Hum Retroviruses. 2008 Jun
• Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infection.
  Harrington, P.R., Connell, M.J., Meeker, R.B., Johnson, P.R., Swanstrom, R.> ;J Infect Dis. 2007 Oct 1
• HIV vaccine design: insights from live attenuated SIV vaccines.
  Koff, W.C., Johnson, P.R., Watkins, D.I., Burton, D.R., Lifson, J.D., Hasenkrug, K.J., McDermott, A.B., Schultz, A., Zamb, T.J., Boyle, R., Desrosiers, R.C.> ;Nat Immunol. 2006 Jan
• Molecular characterization of adeno-associated viruses infecting children.
  Chen, C., Jensen, R.L., Schnepp, B.C., Connell, M.J., Shell, R., Sferra, T.J., Bartlett, J.S., Clark, K.R., Johnson, P.R.> ;J Virol. 2005 Dec
• Characterization of adeno-associated virus genomes isolated from human tissues.
  Schnepp, B.C., Jensen, R.L., Chen, C., Johnson, P.R., Clark, K.R.> ;J Virol. 2005 Dec
• Macroscopic tunnel splittings in superconducting phase qubits.
  Johnson, P. R.,Parsons, W. T.,Strauch, F. W.,Anderson, J. R.,Dragt, A. J.,Lobb, C. J.,Wellstood, F. C.> ;Phys Rev Lett. 2005 May 13
• Spectroscopy of three-particle entanglement in a macroscopic superconducting circuit.
  Xu, H., Strauch, F.W., Dutta, S.K., Johnson, P.R., Ramos, R.C., Berkley, A.J., Paik, H., Anderson, J.R., Dragt, A.J., Lobb, C.J., Wellstood, F.C.> ;Phys Rev Lett. 2005 Jan 21
• Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.
  Johnson, P.R., Schnepp, B.C., Connell, M.J., Rohne, D., Robinson, S., Krivulka, G.R., Lord, C.I., Zinn, R., Montefiori, D.C., Letvin, N.L., Clark, K.R.> ;J Virol. 2005 Jan
• Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.
  Haigwood, N.L., Montefiori, D.C., Sutton, W.F., McClure, J., Watson, A.J., Voss, G., Hirsch, V.M., Richardson, B.A., Letvin, N.L., Hu, S., Johnson, P.R.> ;J Virol. 2004 Jun
• Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.
  Rybarczyk, B.J., Montefiori, D., Johnson, P.R., West, A., Johnston, R.E., Swanstrom, R.> ;J Virol. 2004 Apr
• Quantum logic gates for coupled superconducting phase qubits.
  Strauch, F.W., Johnson, P.R., Dragt, A.J., Lobb, C.J., Anderson, J.R., Wellstood, F.C.> ;Phys Rev Lett. 2003 Oct 17
• Genetic fate of recombinant adeno-associated virus vector genomes in muscle.
  Schnepp, B.C., Clark, K.R., Klemanski, D.L., Pacak, C.A., Johnson, P.R.> ;J Virol. 2003 Mar
• Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer.
  Lewis, A.D., Chen, R., Montefiori, D.C., Johnson, P.R., Clark, K.R.> ;J Virol. 2002 Sep
• Vector-mediated antibody gene transfer for infectious diseases.
  Schnepp, B. C.,Johnson, P. R.> ;Adv. Exp. Med. Biol.. 2015 Mar 12
• Gene-based vaccine approaches for respiratory syncytial virus.
  Loomis, R. J.,Johnson, P. R.> ;Curr. Top. Microbiol. Immunol.. 2013 Dec 24
• Join now to see all